$23.20
1.69% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US86881A1007
Symbol
SGRY

Surgery Partners, Inc. Stock price

$23.20
+3.00 14.85% 1M
+0.69 3.07% 6M
+2.03 9.59% YTD
-2.27 8.91% 1Y
-16.50 41.56% 3Y
+10.05 76.43% 5Y
+5.09 28.11% 10Y
Nasdaq, Closing price Tue, May 20 2025
-0.40 1.69%
ISIN
US86881A1007
Symbol
SGRY
Sector

Key metrics

Market capitalization $2.97b
Enterprise Value $8.45b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 48.78
EV/Sales (TTM) EV/Sales 2.66
P/S ratio (TTM) P/S ratio 0.94
P/B ratio (TTM) P/B ratio 1.71
Revenue growth (TTM) Revenue growth 13.54%
Revenue (TTM) Revenue $3.17b
EBIT (operating result TTM) EBIT $455.50m
Free Cash Flow (TTM) Free Cash Flow $173.30m
Cash position $229.30m
EPS (TTM) EPS $-1.53
P/E forward 53.64
P/S forward 0.88
EV/Sales forward 2.50
Short interest 15.79%
Show more

Is Surgery Partners, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Surgery Partners, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Surgery Partners, Inc. forecast:

9x Buy
75%
3x Hold
25%

Analyst Opinions

12 Analysts have issued a Surgery Partners, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Surgery Partners, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
3,173 3,173
14% 14%
100%
- Direct Costs 2,576 2,576
15% 15%
81%
597 597
8% 8%
19%
- Selling and Administrative Expenses - -
- Research and Development Expense - -
-
-
611 611
10% 10%
19%
- Depreciation and Amortization 155 155
22% 22%
5%
EBIT (Operating Income) EBIT 456 456
6% 6%
14%
Net Profit -193 -193
32,333% 32,333%
-6%

In millions USD.

Don't miss a Thing! We will send you all news about Surgery Partners, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Surgery Partners, Inc. Stock News

Neutral
Seeking Alpha
8 days ago
Surgery Partners, Inc. (NASDAQ:SGRY ) Q1 2025 Earnings Conference Call May 12, 2025 8:30 AM ET Company Participants Eric Evans - Chief Executive Officer David Doherty - Executive Vice President and Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Joanna Gajuk - Bank of America Benjamin Rossi - JPMorgan Chase Sarah James - Cantor Fitzgerald Andrew Mok - Barclays A...
Neutral
GlobeNewsWire
9 days ago
BRENTWOOD, Tenn., May 12, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2025.
Neutral
GlobeNewsWire
15 days ago
ATLANTA, May 06, 2025 (GLOBE NEWSWIRE) -- Advanced Aesthetics Plastic Surgery has joined Ascend Aesthetic Partners, forming a partnership rooted in shared values of collaboration, clinical excellence, and continuous learning. With the addition of Dr. Joseph Raniere, Jr., Dr. Edward S. Gronka, and Dr. Takintope Akinbiyi as Partner Physicians, as well as Amanda Fowler, PA-C, Ascend now includes 2...
More Surgery Partners, Inc. News

Company Profile

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.

Head office United States
CEO J. Evans
Employees 15,000
Founded 2004
Website www.surgerypartners.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today